Real-time enrollment status for this pulmonary hypertension clinical trial
Current Status
Recruiting
Checked: October 20, 2026 at 11:08 PM UTC
| NCT Number | NCT07333183 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Pulmovant, Inc. |
| Last Updated on CT.gov | September 2, 2026 (Sep 2, 2026) |
As of October 20, 2026: Clinical trial NCT07333183 is currently recruiting participants. This phase2 study for pulmonary hypertension is actively seeking new participants at 13 locations across the United States. The study is sponsored by Pulmovant, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07333183 is actively recruiting participants as of October 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07333183 was last updated Sep 2, 2026 (September 2, 2026). HelloStudys verifies this status automatically.